economy in 2020 from the previous revised projection at 5.3% contraction to 8.1% contraction and clarified its forecast for recovery of Thai economy to be more like “Swoosh-shaped” pattern with major

, of revising down revenue projection, we expect EBITDA to be flat supported by the above mentioned ongoing cost program . Dividend policy at minimum 70% of net profit AIS is committed to driving long

operational processes, as well as revamped network utilization management to improve capex efficiency . As a result, of revising down revenue projection, we expect EBITDA to be flat supported by the above

1 25 May 2020 Subject: Notification on Resolution of the Board of Directors’ Meeting No. 5/2020, Change of Directors and Directors’ Power, Entering into Connected Transaction, Entering into Transaction on Acquisition of Assets and Determination of the 2020 Annual General Meeting of Shareholders To: Director and Manager The Stock Exchange of Thailand Enclosure 1. Information Memorandum on the Acquisition of Assets (Schedule 1) and the Entry into Connected Transaction of Nation Broadcasting Corpor...

Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales

year to be in parallel with the plunge in sales revenue. Nevertheless, some of the sales expenses did not adjust promptly and did not fully mirror the slowdown in revenue as there is a lead time for

ongoing outbreak of COVID–19, forcing many customers to adjust their working method which have an effect on the operation and delivery of the Company's projects that cause the operation to be delayed than

reducing production cost and also negotiating with customers to review and adjust selling price every quarter. 2.2. Distribution costs for 2018 was in the amount of 4.95 million baht, increased by 1.16

with the plunge in sales revenue. Nevertheless, some of the sales expenses did not adjust promptly and did not fully mirror the slowdown in revenue as there is a lead time for certain expenses that the

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change